Privia Health targets 19.5% adjusted EBITDA growth for 2026 while expanding national footprint to 24 states [Seeking Alpha]
Privia Health Group, Inc. (PRVA)
Company Research
Source: Seeking Alpha
CEO Parth Mehrotra stated that "Privia Health delivered a very strong 2025 as we continue to execute extremely well and drive growth across our markets." He highlighted new provider signings Quick Insights Privia Health projects approximately 20% adjusted EBITDA growth at the midpoint of 2026 guidance, strong free cash flow conversion at 80%, and expects to end 2026 with about $600 million in cash, assuming no new acquisitions. Key growth drivers include provider expansion, acquisitions (like the Evolent Health ACO business), practice collections, value-based attributed lives, and technology/AI investments. Risks cited are challenges in payment landscape, acquisition integration, variability in practice collections, elevated utilization trends, and regulatory changes. Management is investing in technology and AI, expecting productivity enhancements and potential for future margin improvement, while pursuing applications that support operational and cost efficiencies. More T
Show less
Read more
Impact Snapshot
Event Time:
PRVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRVA alerts
High impacting Privia Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
PRVA
News
- Privia Health Group (PRVA) had its price target lowered by Citigroup Inc. from $34.00 to $32.00. They now have a "buy" rating on the stock.MarketBeat
- Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration [Yahoo! Finance]Yahoo! Finance
- Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry CollaborationBusiness Wire
- Privia Health price target raised to $33 from $31 at Truist [Yahoo! Finance]Yahoo! Finance
- Privia Health Group (PRVA) had its price target raised by Truist Financial Corporation from $31.00 to $33.00. They now have a "buy" rating on the stock.MarketBeat
PRVA
Earnings
- 2/26/26 - Beat
PRVA
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- PRVA's page on the SEC website